This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Learn what to include in your crypto portfolio to maximize returns. Make informed choices for a balanced investment.
23,861 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
The first quarter of 2026 offers clues about corporate health and future growth. This guide explains how to read a go...
As Berkshire's new leader, Greg Abel faces a massive cash pile. This article examines why Alphabet is the target, wha...
Turning Point Brands stock captured attention with a double-digit sales lift and solid earnings signs that stunned ma...
Broadcom is moving deeper into AI infrastructure, signaling a shift that could influence chip design, data-center cos...
As AI expands data center demand, Micron sits at the center of memory supply. This guide breaks down the odds for 202...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
Two platform leaders redefine how we shop and travel. This guide breaks down which stock—DoorDash or Uber Technologie...
Dell Technologies grabbed headlines as its AI-focused strategy started to show momentum. This piece breaks down why d...
Investors piled into Nextpower after strong 2026 results and a strategic acquisition. This article breaks down the ca...
SpaceX hovers around $135 ahead of a pivotal Starship test. This report weighs the case for spacex $135: should space...
A large investment pledge could reshape U.S. energy markets. This article explains what to watch and highlights two s...